| 臺大學術典藏 |
2022-02-16T03:16:56Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; YU-YUN SHAO; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-15T06:22:43Z |
Invasive Pathobionts Contribute to Colon Cancer Initiation by Counterbalancing Epithelial Antimicrobial Responses
|
LINDA CHIA-HUI YU; Wei S.-C.; Li Y.-H.; Lin P.-Y.; Chang X.-Y.; Weng J.-P.; Shue Y.-W.; Liang-Chuan Lai; Wang J.-T.; Jeng Y.-M.; Ni Y.-H. |
| 臺大學術典藏 |
2022-02-14T07:10:48Z |
Molecular features of primary hepatic undifferentiated carcinoma
|
JIA-HUEI TSAI; Jeng Y.-M.; Lee C.-H.; Liau J.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:47Z |
Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity with Frequent pTERT / TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection
|
JIA-HUEI TSAI; Liau J.-Y.; Lee C.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-02-08T06:27:19Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
Hsu C.-L.; DA-LIANG OU; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; Jeng Y.-M.; Hsu C. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; CHIH-HUNG HSU; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-01-25T05:10:47Z |
Interferon-�\ reduces insulin resistance and �]-cell secretion in responders among patients with chronic hepatitis B and C
|
Tai T.-Y.; Lu J.-Y.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Lee C.-Z.; Lee H.-S.; Chuang L.-M.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-01-25T05:10:37Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
Liu C.-J.; Jeng Y.-M.; CHI-LING CHEN; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:06Z |
Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
|
Huang S.-F.; Chang I.-C.; Hong C.-C.; Yen T.-C.; CHI-LING CHEN; Wu C.-C.; Tsai C.-C.; Ho M.-C.; Lee W.-C.; Yu H.-C.; Shen Y.-Y.; Eng H.-L.; Wang J.; Tseng H.-H.; Jeng Y.-M.; Yeh C.-T.; Chen C.-L.; Chen P.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-01-24T09:32:26Z |
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients
|
CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Jeng Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:22Z |
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C
|
CHUN-JEN LIU; Jeng Y.-M.; Chen P.-J.; Lai M.-Y.; Yang H.-C.; Huang W.-L.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:20Z |
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
|
CHUN-JEN LIU; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; Yang W.-S.; Lai M.-Y.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:01Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
CHUN-JEN LIU; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:43Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:35Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; CHUN-JEN LIU; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:31:31Z |
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
|
Li Y.-T.; CHUN-JEN LIU; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Wu H.-L. |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; CHIUN HSU; Hsieh C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-01-20T07:58:02Z |
The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma
|
Chang H.-H.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Jeng Y.-M.; Jou S.-T. |
| 臺大學術典藏 |
2022-01-20T07:58:01Z |
MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients
|
Chang H.-H.; Tseng Y.-F.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Lin K.-H.; Jou S.-T.; Hsu W.-M.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-01-07T06:06:02Z |
Solid pseudopapillary neoplasms of the pancreas: Is there a pathologic basis for the observed gender differences in incidence?
|
Tien Y.-W.; Ser K.-H.; Hu R.-H.; CHIH-YUAN LEE; Jeng Y.-M.; Lee P.-H. |
| 臺大學術典藏 |
2022-01-07T06:05:48Z |
Human pancreatic afferent and efferent nerves: Mapping and 3-D illustration of exocrine, endocrine, and adipose innervation
|
Chien H.-J.; Chiang T.-C.; Peng S.-J.; Chung M.-H.; Chou Y.-H.; CHIH-YUAN LEE; Jeng Y.-M.; Tien Y.-W.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-07T06:05:48Z |
Lymphatic vessel remodeling and invasion in pancreatic cancer progression
|
Shen C.-N.; Goh K.-S.; Huang C.-R.; Chiang T.-C.; CHIH-YUAN LEE; Jeng Y.-M.; Peng S.-J.; Chien H.-J.; Chung M.-H.; Chou Y.-H.; Hsieh C.-C.; Kulkarni S.; Pasricha P.J.; Tien Y.-W.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-07T06:05:45Z |
Local islet remodelling associated with duct lesion–islet complex in adult human pancreas
|
Tien Y.-W.; Chien H.-J.; Chiang T.-C.; Chung M.-H.; CHIH-YUAN LEE; Peng S.-J.; Chen C.-C.; Chou Y.-H.; Hsiao F.-T.; Jeng Y.-M.; Tang S.-C. |
| 臺大學術典藏 |
2021-12-09T08:29:15Z |
Erratum: Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling (Oncogene (2012) 31 (2401-2411) DOI: 10.1038/onc.2011.423)
|
Yang, M. H.; Lin, B. R.; HSIN-CHIEH CHANG; Chen, S. T.; Lin, S. K.; Kuo, M. Y.P.; Jeng, Y. M.; Kuo, M. L.; Chang, C. C. |
